Improving Management of Type 2 Diabetes Using Home-Based Telemonitoring: Cohort Study

Authors: Milani, Richard, Chava, Pavan, Wilt, Jonathan, Entwisle, Jonathan, Karam, Susan, Burton, Jeffrey, Blonde, Lawrence

Source: JMIR Diabetes, Vol 6, Iss 2, p e24687 (2021)

Subject Terms: Diseases of the endocrine glands. Clinical endocrinology, RC648-665

File Description: electronic resource

Relation: https://diabetes.jmir.org/2021/2/e24687; https://doaj.org/toc/2371-4379

Access URL: https://doaj.org/article/73073489c02b48eca9fa19eff128f1f5

American Association of Clinical Endocrinology Consensus Statement: Comprehensive Type 2 Diabetes Management Algorithm – 2023 Update

Authors: Samson, Susan L., Vellanki, Priyathama, Blonde, Lawrence, Christofides, Elena A., Galindo, Rodolfo J., Hirsch, Irl B., Isaacs, Scott D., Izuora, Kenneth E., Low Wang, Cecilia C., Twining, Christine L., Umpierrez, Guillermo E., Valencia, Willy Marcos

Source: In Endocrine Practice May 2023 29(5):305-340

American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan—2022 Update

Authors: Blonde, Lawrence, Umpierrez, Guillermo E., Reddy, S. Sethu, McGill, Janet B., Berga, Sarah L., Bush, Michael, Chandrasekaran, Suchitra, DeFronzo, Ralph A., Einhorn, Daniel, Galindo, Rodolfo J., Gardner, Thomas W., Garg, Rajesh, Garvey, W. Timothy, Hirsch, Irl B., Hurley, Daniel L., Izuora, Kenneth, Kosiborod, Mikhail, Olson, Darin, Patel, Shailendra B., Pop-Busui, Rodica, Sadhu, Archana R., Samson, Susan L., Stec, Carla, Tamborlane, William V., Jr., Tuttle, Katherine R., Twining, Christine, Vella, Adrian, Vellanki, Priyathama, Weber, Sandra L.

Source: In Endocrine Practice October 2022 28(10):923-1049

Efficacy of liraglutide added to sodium‐glucose cotransporter‐2 inhibitors in type 2 diabetes, stratified by baseline characteristics: Post‐hoc analysis of LIRA‐ADD2SGLT2i

Authors: Blonde, Lawrence, Fainberg, Udi, Kaltoft, Margit S., Mosenzon, Ofri, Ramesh, Chethana, Rea, Rosangela

Source: Diabetes, obesity & metabolism. 23(10):2234-2241

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100128928972.0x000001&indx=1&recIds=ETOCvdc_100128928972.0x000001

Insulin glargine 300 units/mL for the treatment of individuals with type 2 diabetes in the real world: A review of the DELIVER programme

Authors: Blonde, Lawrence, Bailey, Timothy, Sullivan, Sean D., Freemantle, Nick

Source: Diabetes, obesity & metabolism. 23(8):1713-1721

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100123453284.0x000001&indx=1&recIds=ETOCvdc_100123453284.0x000001

Switching to iGlarLixi versus continuation of a daily or weekly glucagon‐like peptide‐1 receptor agonist (GLP‐1 RA) in insufficiently controlled type 2 diabetes: A LixiLan‐G trial subgroup analysis by HbA1c and GLP‐1 RA use at screening

Authors: Rosenstock, Julio, Blonde, Lawrence, Aroda, Vanita R., Frias, Juan, Souhami, Elisabeth, Ji, Chen, Niemoeller, Elisabeth, Del Prato, Stefano

Source: Diabetes, obesity & metabolism. 23(6):1331-1341

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100120638435.0x000001&indx=1&recIds=ETOCvdc_100120638435.0x000001

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2020 Executive Summary

Authors: Garber, Alan J., Handelsman, Yehuda, Grunberger, George, Einhorn, Daniel, Abrahamson, Martin J., Barzilay, Joshua I., Blonde, Lawrence, Bush, Michael A., DeFronzo, Ralph A., Garber, Jeffrey R., Garvey, W.Timothy, Hirsch, Irl B., Jellinger, Paul S., McGill, Janet B., Mechanick, Jeffrey I., Perreault, Leigh, Rosenblit, Paul D., Samson, Susan, Umpierrez, Guillermo E.

Source: In Endocrine Practice January 2020 26(1):107-139

Liraglutide as add‐on to sodium‐glucose co‐transporter‐2 inhibitors in patients with inadequately controlled type 2 diabetes: LIRA‐ADD2SGLT2i, a 26‐week, randomized, double‐blind, placebo‐controlled trial

Authors: Blonde, Lawrence, Belousova, Lidia, Fainberg, Udi, Garcia‐Hernandez, Pedro A., Jain, Sunil M., Kaltoft, Margit S., Mosenzon, Ofri, Nafach, Jalal, Palle, Mads Sundby, Rea, Rosangela

Source: Diabetes, obesity & metabolism. 22(6):929-937

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100114723099.0x000001&indx=1&recIds=ETOCvdc_100114723099.0x000001

Efficacy and safety of iGlarLixi versus IDegLira in adults with type 2 diabetes inadequately controlled by glucagon‐like peptide‐1 receptor agonists: a systematic literature review and indirect treatment comparison

Authors: Home, Philip D., Aroda, Vanita R., Blonde, Lawrence, Guyot, Patricia, Shaunik, Alka, Fazeli, Mir Sohail, Goswami, Hardik, Kalra, Sanjay, Pourrahmat, Mir‐Masoud

Source: Diabetes, obesity & metabolism. 22(11):2170-2178

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111609985.0x000001&indx=1&recIds=ETOCvdc_100111609985.0x000001

Insulin glargine 300 U/mL versus first‐generation basal insulin analogues in insulin‐naïve adults with type 2 diabetes: 12‐month outcomes of ACHIEVE Control, a prospective, randomized, pragmatic real‐life clinical trial

Authors: Meneghini, Luigi, Blonde, Lawrence, Gill, Jasvinder, Dauchy, Arnaud, Bacevicius, Andrius, Strong, Jodi, Bailey, Timothy S.

Source: Diabetes, obesity & metabolism. 22(11):1995-2003

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111609927.0x000001&indx=1&recIds=ETOCvdc_100111609927.0x000001

Insulin glargine/lixisenatide fixed‐ratio combination (iGlarLixi) compared with premix or addition of meal‐time insulin to basal insulin in people with type 2 diabetes: A systematic review and Bayesian network meta‐analysis

Authors: Home, Philip, Blonde, Lawrence, Kalra, Sanjay, Ji, Linong, Guyot, Patricia, Brulle‐Wohlhueter, Claire, Murray, Erin, Shah, Roshan, Sayre, Toby, Shaunik, Alka

Source: Diabetes, obesity & metabolism. 22(11):2179-2188

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100111610011.0x000001&indx=1&recIds=ETOCvdc_100111610011.0x000001

Impact of disease duration and β‐cell reserve on the efficacy of switching to iGlarLixi in adults with type 2 diabetes on glucagon‐like peptide‐1 receptor agonist therapy: Exploratory analyses from the LixiLan‐G trial

Authors: Del Prato, Stefano, Frias, Juan Pablo, Blonde, Lawrence, Aroda, Vanita R., Shehadeh, Niam, Saremi, Aramesh, Dex, Terry, Niemoeller, Elisabeth, Souhami, Elisabeth, Liu, Minzhi, Rosenstock, Julio

Source: Diabetes, obesity & metabolism. 22(9):1567-1576

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100107989796.0x000001&indx=1&recIds=ETOCvdc_100107989796.0x000001

Overview of Therapeutic Inertia in Diabetes: Prevalence, Causes, and Consequences

Authors: Karam, Susan L., Dendy, Jared, Polu, Shruti, Blonde, Lawrence

Source: Diabetes spectrum. 33(1):8-15

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCRN623111578&indx=1&recIds=ETOCRN623111578

Real-World Comparative Effectiveness of Canagliflozin Versus Empagliflozin and Dapagliflozin in Patients with Type 2 Diabetes in the United States

Authors: Blonde, Lawrence, Patel, Charmi, Wu, Bingcao, Chen, Yen-Wen, Pericone, Christopher D., Bookhart, Brahim

Source: Advances in therapy. 38(1):594-606

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100194066079.0x000001&indx=1&recIds=ETOCvdc_100194066079.0x000001

Fixed-Ratio Combination of Insulin and GLP-1 RA in Patients with Longstanding Type 2 Diabetes: A Subanalysis of LixiLan-L

Authors: Blonde, Lawrence, Berard, Lori, Saremi, Aramesh, Huang, Yao, Aroda, Vanita R., Raccah, Denis

Source: Diabetes therapy. 11(4):1007-1015

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172273322.0x000001&indx=1&recIds=ETOCvdc_100172273322.0x000001

Glycemic Control Following GLP-1 RA or Basal Insulin Initiation in Real-World Practice: A Retrospective, Observational, Longitudinal Cohort Study

Authors: Peng, Xuejun Victor, McCrimmon, Rory J., Shepherd, Leah, Boss, Anders, Lubwama, Robert, Dex, Terry, Skolnik, Neil, Ji, Linong, Avogaro, Angelo, Blonde, Lawrence

Source: Diabetes therapy. 11(11):2629-2645

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100172273634.0x000001&indx=1&recIds=ETOCvdc_100172273634.0x000001

Clinical review of the efficacy and safety of oral semaglutide in patients with type 2 diabetes compared with other oral antihyperglycemic agents and placebo

Authors: Lavernia, Frank, Blonde, Lawrence

Source: Postgraduate medicine. 132:15-25

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100110744580.0x000001&indx=1&recIds=ETOCvdc_100110744580.0x000001

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2019 Executive Summary

Authors: Garber, Alan J., Abrahamson, Martin J., Barzilay, Joshua I., Blonde, Lawrence, Bloomgarden, Zachary T., Bush, Michael A., Dagogo-Jack, Samuel, DeFronzo, Ralph A., Einhorn, Daniel, Fonseca, Vivian A., Garber, Jeffrey R., Garvey, W. Timothy, Grunberger, George, Handelsman, Yehuda, Hirsch, Irl B., Jellinger, Paul S., McGill, Janet B., Mechanick, Jeffrey I., Rosenblit, Paul D., Umpierrez, Guillermo E. ^*

Source: In Endocrine Practice January 2019 25(1):69-101

Glucagon-Like Peptide 1 Receptor Agonists For Type 2 Diabetes: A Comprehensive Review of How to Weigh The Options, Select the Right Patients, and Maximize Benefits

Authors: Blonde, Lawrence, Fonseca, Vivian ^*

Source: In Endocrine Practice October 2018 24 Supplement 2:8-19

Consensus Statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the Comprehensive Type 2 Diabetes Management Algorithm – 2018 Executive Summary

Authors: Garber, Alan J., Abrahamson, Martin J., Barzilay, Joshua I., Blonde, Lawrence, Bloomgarden, Zachary T., Bush, Michael A., Dagogo-Jack, Samuel, DeFronzo, Ralph A., Einhorn, Daniel, Fonseca, Vivian A., Garber, Jeffrey R., Garvey, W. Timothy, Grunberger, George, Handelsman, Yehuda, Hirsch, Irl B., Jellinger, Paul S., McGill, Janet B., Mechanick, Jeffrey I., Rosenblit, Paul D., Umpierrez, Guillermo E.

Source: In Endocrine Practice January 2018 24(1):91-121